ArticleThe Journal of antimicrobial chemotherapy2024

Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa.

Thomas P Lodise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.